Rossari Biotech Ltd.

•

rossari.comBSE: 543213NSE: ROSSARI

Market Cap₹ 2,518 Cr.

Current Price

High / Low₹ 690 / 375

Stock P/E16.7

Book Value₹ 225

Price to Book1.73

Dividend Yield0.11 %

ROCE16.7 %

ROE12.5 %

Face Value₹ 2

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Chemicals

Hold

The available domestic chemical proxies are mixed to weak. Fertilizers output was -8.0% YoY (2026-07) and sale quantity of fertilisers was 0.0% YoY (2026-05), although that high-frequency barometer is stale. FPI positioning is less negative than before, with net 3-month outflow only INR -11 crore versus INR -1229 crore in the prior 3 months to 2026-08-31, but the weak sector driver argues for a neutral stance.

Confidence

55%

View full sector analysis →

PROS

Latest quarter profit grew 30.6% YoY, showing strong momentum
Company has delivered good sales growth of 20.5% CAGR over last 5 years
Company comfortably covers its interest (15.3x coverage)
Stock looks reasonably valued - P/E of 16.7 is below its historical median
Company generates healthy free cash flow
Company has a consistent dividend-paying track record

CONS

Receivables are growing faster than sales - a possible quality concern
Total debt has risen sharply - up 319.7% year on year
Though reporting repeated profits, the company pays out little dividend (1.9%)

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

ChemicalsChemicalsChemicals

Part ofNIFTY 50 NIFTY 500 NIFTY LARGEMIDCAP 250 NIFTY 100 NIFTY 200

S.No.	Name
1.	SOLARINDS	22470.95	102.11	203339.75	0.05	666.37	88.98	3668.20	70.26	38.16	27.91
2.	PIDILITIND	1589.00	61.06	161741.08	1.35	8835.10	1202.86	45515.50	1112.74	32.38	26.28
3.	SRF	2527.85	34.66	74931.75	0.36	758.87	75.53	5033.26	34.63	14.21	24.57
4.	FLUOROCHEM	4678.50	83.57	51393.32	0.06	219.00	19.02	1588.00	23.97	9.58	26.83
5.	NAVINFLUOR	8728.90	56.71	44786.34	0.17	243.31	107.67	1045.08	44.07	21.39	34.17
6.	GODREJIND	1144.10	32.78	38539.13	0.00	523.36	-27.85	5448.09	22.16	10.64	12.82
7.	DEEPAKNTR	1649.05	28.72	22491.89	0.45	345.01	207.36	2577.60	36.39	11.58	20.96
8.	AETHER	1643.35	92.74	21811.83	0.00	62.75	33.45	326.56	27.49	11.65	31.47
9.	ATUL	6312.05	23.36	18583.78	0.48	253.93	91.85	1847.95	25.03	15.05	21.41
10.	AARTIIND	503.75	34.41	18272.36	0.20	155.00	260.47	2387.00	42.42	6.95	16.00
11.	DEEPAKFERT	1345.50	17.32	17042.49	0.74	490.04	100.95	3256.26	22.47	12.12	25.96
12.	ROSSARI	454.55	16.71	2517.94	0.11	35.09	4.46	697.20	28.23	14.84	11.63

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	258	332	299	314	301	336	368	427	366	420	451	516	482
	223	290	258	272	261	292	318	374	322	369	400	453	438
Operating Profit	35	42	41	42	40	44	50	52	44	50	50	64	44
OPM %	13.60%	12.75%	13.77%	13.30%	13.24%	13.18%	13.57%	12.23%	12.02%	12.02%	11.18%	12.32%	9.17%
	1	2	2	1	1	1	1	2	2	1	1	23	2
Interest	2	3	3	2	2	2	2	3	3	2	4	4	4
Depreciation	6	6	6	7	6	7	7	8	7	7	7	9	8
Profit before Tax	29	36	35	35	33	37	41	44	35	42	40	74	46
Tax %	25.89%	25.69%	26.61%	24.69%	25.53%	25.71%	25.76%	26.20%	25.99%	25.54%	23.62%	25.59%	26.18%
Net Profit	22	26	26	26	24	27	31	32	26	31	31	55	34
	3.91	4.78	4.62	4.74	4.40	4.96	5.53	5.85	4.74	5.64	5.53	9.88	6.19

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	233	292	516	600	690	1,073	975	1,203	1,432	1,752	1,869
	209	247	438	495	570	953	855	1,046	1,254	1,558	1,660
Operating Profit	24	45	78	105	121	120	120	157	178	194	209
OPM %	10.50%	15.28%	15.05%	17.50%	17.50%	11.16%	12.32%	13.05%	12.41%	11.07%	11.16%
	1	1	1	4	10	16	6	11	14	41	27
Interest	2	1	3	4	3	3	5	10	10	13	14
Depreciation	4	5	12	17	22	26	26	24	28	31	32
Profit before Tax	19	39	63	88	106	107	96	134	155	191	202
Tax %	16.74%	26.65%	27.83%	25.63%	25.37%	25.50%	25.36%	25.71%	25.83%	25.24%	25.32%
Net Profit	16	29	46	66	79	79	71	100	115	143	151
EPS	35.44	65.74	9.46	13.28	15.25	14.40	12.90	18.04	20.72	25.79	—
Dividend Payout %	0.00%	30.42%	4.80%	3.87%	3.28%	3.46%	3.86%	2.77%	2.41%	1.94%	—

COMPOUNDED SALES GROWTH

10 Years:: 26%
5 Years:: 20%
3 Years:: 22%

COMPOUNDED PROFIT GROWTH

10 Years:: 45%
5 Years:: 13%
3 Years:: 26%

STOCK PRICE CAGR

10 Years:: —
5 Years:: -20%
3 Years:: -19%
1 Year:: -27%

RETURN ON EQUITY

10 Years:: 22%
5 Years:: 11%
3 Years:: 12%
Last Year:: 12%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	4	4	4	10	10	11	11	11	11	11
	56	85	116	273	392	770	844	946	1,064	1,202
	26	24	6	61	0	0	56	56	47	139
Trade Payables	32	38	106	97	124	116	178	226	286	367
	3	8	49	80	102	135	167	207	244	298
Total Liabilities	121	159	281	521	628	1,033	1,256	1,445	1,652	2,017
	37	44	74	94	171	177	157	167	179	218
Capital Work in Progress	8	10	3	22	0	1	11	25	34	105
	0	3	0	15	9	381	493	528	538	548
	24	35	55	58	89	107	113	151	179	180
	0	0	0	0	0	0	0	302	375	518
Cash & Bank	2	1	6	127	86	35	80	26	16	52
	51	66	143	205	273	331	402	246	331	396
Total Assets	121	159	281	521	628	1,033	1,256	1,445	1,652	2,017

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	5	32	92	76	83	57	138	74	92	59
Cash from Investing	-6	-16	-40	-187	-37	-318	-161	-70	-70	-101
Cash from Financing	3	-6	-26	155	-29	297	61	-22	-32	79
	-0	-1	6	23	-14	12	14	-18	-10	36

Ratios

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026

Shareholding Pattern

Numbers in percentages

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	68.32	68.27	68.19	68.18	68.17	68.17	68.16	68.15	68.14
	3.83	3.74	3.74	3.98	3.48	2.70	2.32	2.18	2.03
	16.87	17.34	17.47	17.59	17.84	18.18	18.25	18.21	14.64
Government	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	10.98	10.65	10.60	10.25	10.51	10.95	11.26	11.46	15.20

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-08-06

Updates

2026-08-06 - Intimation of non-participation in the investors and analysts meet scheduled on Monday, August 10, 2026.

2026-08-03

Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-03 - Intimation of Analyst/ Institutional Investor Meet/ Con. Call/Updates.

2026-07-24

Analysts/Institutional Investor Meet/Con. Call Updates

2026-07-24 - Intimation of Transcript of Q1 FY 27 for the Earnings Conference Call held on July 20, 2026.

2026-07-20

Shareholders meeting

2026-07-20 - Outcome of 17th Annual General Meeting of the Members of the Company along with Proceedings, Voting Results and Scrutinizers Report.

2026-07-20

Analysts/Institutional Investor Meet/Con. Call Updates

2026-07-20 - Audio recording of Earnings Conference Call for Q1 FY 27.

2026-07-20

ESOP/ESOS/ESPS

2026-07-20 - Update on Grant of Options

2026-07-19

Press Release

2026-07-19 - Rossari Biotech Limited informed the Exchange regarding Press Release dated July 18, 2026 titled " Rossari Biotech announces Q1 FY 27 results".

2026-07-19

Investor Presentation

2026-07-19 - Rossari Biotech Limited has informed the Exchange about Investor Presentation

2026-07-19

Copy of Newspaper Publication

2026-07-19 - Newspaper publication of extract of Consolidated Unaudited Financial Results for the Quarter ended June 30, 2026.

News

Recent coverage and analyst commentary for ROSSARI

Loading news…

🤖

AI Stock Analyst

Rossari Biotech Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account